# AtriCure (ATRC) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/ATRC
## Company Profile
- Ticker: ATRC
- Exchange: NASDAQ
- Sector: MedTech
- Location: United States
- Tags: MedTech
## Stock Data
- Close: 39.49 USD
- Market cap: 1309575484.2 USD
- Last updated: 2026-08-06
## Business Overview
### Atrial Fibrillation Surgery
AtriCure develops medical devices and procedures for the surgical treatment of atrial fibrillation. Its products are used by cardiac surgeons to create controlled lesions that interrupt abnormal electrical pathways and restore a more regular heart rhythm.
### Ablation Technologies
The Isolator Synergy Ablation System is FDA approved for persistent atrial fibrillation and anchors AtriCure’s surgical ablation portfolio. The company also offers the Hybrid AF Therapy, a minimally invasive approach for patients with long-standing persistent atrial fibrillation.
### Adjacent Surgical Markets
AtriCure’s broader portfolio includes left atrial appendage management and post-operative pain-management products. These complementary technologies allow the company to serve multiple needs within cardiac and thoracic surgery using a common physician and hospital customer base.
## Why The Stock Is Moving

As of Aug 6, 2026, ATRC closed up 0.38% at $39.49. No new same-company headline was identified in the current news window.

## Future Catalysts

- AtriCure's catalysts are AF ablation adoption, left-atrial appendage management, and continued procedure growth in cardiac surgery. The company improves when its installed physician base keeps converting into repeatable use.

## Recent News
- 2026-07-27 12:00 EST — [AtriCure to Participate at Upcoming Investor Conferences](https://biopharmsignal.com/news/ATRC/atricure-to-participate-at-upcoming-investor-conferences-6f05f34e) — Source: AtriCure
- 2026-07-23 20:01 EST — [AtriCure Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/ATRC/atricure-reports-second-quarter-2026-financial-results-e6a18a2f) — Source: AtriCure
- 2026-07-02 12:00 EST — [AtriCure to Announce Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/ATRC/atricure-to-announce-second-quarter-2026-financial-results-ccf9a74f) — Source: AtriCure
- 2026-05-27 12:00 EST — [AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference](https://biopharmsignal.com/news/ATRC/atricure-to-participate-in-the-goldman-sachs-47th-annual-global-health-care-conference) — Source: AtriCure
- 2026-05-05 20:01 EST — [AtriCure Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/ATRC/atricure-reports-first-quarter-2026-financial-results) — Source: AtriCure